Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndromeCROUCH, Michael A; NAPPI, Jean M; CHEANG, Kai I et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 860-875, issn 1060-0280, 16 p.Article

Unexpected flow cytometric results with two small GPIIb/IIIa blockers : Eptifibatide and tirofibanHEZARD, Nathalie; METZ, Damien; TASSAN-MANGINA, Sophie et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 561-562, issn 0340-6245Article

Optimal duration of Eptifibatide infusion in percutaneous coronary intervention (an ESPRIT Substudy)REBEIZ, Abdallah G; DERY, Jean-Pierre; JOSEPH, Diane et al.The American journal of cardiology. 2004, Vol 94, Num 7, pp 926-929, issn 0002-9149, 4 p.Article

Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibitionKOESTENBERGER, Martin; GALLISTL, Siegfried; CVIRN, Gerhard et al.Blood coagulation & fibrinolysis. 2004, Vol 15, Num 2, pp 131-137, issn 0957-5235, 7 p.Article

Thrombopénies induites par les antagonistes du complexe GPIIbIIIa plaquettaire administrés par voie injectable = Anti-GPIIbIIIa induced thrombocytopeniaLE BELLER, Christine; ALHENC-GELAS, Martine.Hématologie (Montrouge). 2004, Vol 10, Num 1, pp 14-23, issn 1264-7527, 10 p.Article

Intérêt de l'eptifibatide au cours de l'angioplastie de sauvetage avec stenting coronaire après échec de thrombolyse: À propos d'une série de 41 patients = Significance of eptifibatide during salvage angioplasty with coronary stenting after failure of thrombolysisIDIR, M; DELARCHE, N; BANCS, Jl et al.Archives des maladies du coeur et des vaisseaux. 2002, Vol 95, Num 10, pp 903-907, issn 0003-9683Conference Paper

Eptifibatide overdosePARAKH, Sagun; NAIK, Nimesh; ROHATGI, Nidhi et al.International journal of cardiology. 2009, Vol 131, Num 3, pp 430-432, issn 0167-5273, 3 p.Article

Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitorsASTER, Richard H; CURTIS, Brian R; BOUGIE, Daniel W et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 5, pp 569-577, issn 0094-6176, 9 p.Article

Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemiaDERHASCHNIG, Ulla; PACHINGER, Christine; SCHWEEGER-EXELI, Ingrid et al.Thrombosis and haemostasis. 2003, Vol 90, Num 6, pp 1054-1060, issn 0340-6245, 7 p.Article

A novel method to assess platelet inhibition by eptifibatide with Thrombelastograph®KATORI, Nobuyuki; SZLAM, Fania; LEVY, Jerrold H et al.Anesthesia and analgesia. 2004, Vol 99, Num 6, pp 1794-1799, issn 0003-2999, 6 p.Article

Effect of Ca²⁺ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofibanMARCINIAK, Stanley J; JORDAN, Robert E; MASCELLI, Mary A et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 539-543, issn 0340-6245Article

In vitro dose response to different GPIIb/IIIa-antagonists : Inter-laboratory comparison of various platelet function testsHARDER, S; KLINKHARDT, U; BREDDIN, H. K et al.Thrombosis research. 2001, Vol 102, Num 1, pp 39-48, issn 0049-3848Article

Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjectsHOLMES, M. B; SOBEL, B. E; SCHNEIDER, D. J et al.The American journal of cardiology. 1999, Vol 84, Num 2, pp 203-207, issn 0002-9149Article

Association of Eptifibatide and acute profound thrombocytopeniaHONGO, Richard H; BRENT, Bruce N.The American journal of cardiology. 2001, Vol 88, Num 4, pp 428-431, issn 0002-9149Article

Évaluation de l'utilisation d'un inhibiteur de la glycoprotéine IIbIIIa, l'integrilin®, dans un service de cardiologie = Evaluation of a glycoprotein iibiiia receptor inhibitor (Integrilin®) in a cardiology unitWOLFF, E; PISANTE, L; MICHAUD, P et al.Journal de pharmacie clinique (Paris). 2003, Vol 22, Num 2, pp 64-68, issn 0291-1981, 5 p.Article

Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitorsWEBER, Artur-Aron; MEILA, Dan; JACOBS, Collin et al.Thrombosis research. 2002, Vol 106, Num 1, pp 25-29, issn 0049-3848Article

Regulation of CD40L (CD154) and CD62P (p-selectin) Surface Expression upon GPIIb-IIIa Blockade of Platelets from Stable Coronary Artery Disease PatientsBLEAKLEY CHANDLER, A; EARHART, Angela D; SPEICH, Henry E et al.Thrombosis research. 2010, Vol 125, Num 1, pp 44-52, issn 0049-3848, 9 p.Article

No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitorsWEBERA, Artur-Aron; JACOBS, Collin; MEILA, Dan et al.Pharmacogenetics (London). 2002, Vol 12, Num 7, pp 581-583, issn 0960-314X, 3 p.Article

Long-Term Results Following Switch From Abciximab to Eptifibatide During Percutaneous Coronary InterventionKOUTOUZIS, Michael; LAGERQVIST, Bo; OLDGREN, Jonas et al.Clinical cardiology (Mahwah, NJ). 2010, Vol 33, Num 11, pp 686-692, issn 0160-9289, 7 p.Article

Abbreviated Infusion of Eptifibatide After Successful Coronary Intervention : The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) Randomized TrialFUNG, Anthony Y; SAW, Jacqueline; WEBB, John G et al.Journal of the American College of Cardiology. 2009, Vol 53, Num 10, pp 837-845, issn 0735-1097, 9 p.Article

Switch from abciximab to eptifibatide during percutaneous coronary interventionWAHLIN, Magnus; ALBERTSSON, Per; KARLSSON, Thomas et al.International journal of cardiology. 2009, Vol 134, Num 3, pp 393-400, issn 0167-5273, 8 p.Article

The Relative Safety and Efficacy of Abciximab and Eptifibatide in Patients Undergoing Primary Percutaneous Coronary : Intervention Insights From a Large Regional Registry of Contemporary Percutaneous Coronary Intervention. CommentaryGURM, Hitinder S; SMITH, Dean E; ZUGHAIB, Marcel et al.Journal of the American College of Cardiology. 2008, Vol 51, Num 5, pp 529-537, issn 0735-1097, 9 p.Article

Inhibition of platelet aggregation with Eptifibatide, Bivalirudin, and Heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (the pharmacodynamic evaluation of angiomax, clopidogrel with or without integrilin [DEACON] study)SAUCEDO, Jorge F; AUDE, Wady; PACHECO, Rebecca et al.The American journal of cardiology. 2005, Vol 95, Num 12, pp 1453-1456, issn 0002-9149, 4 p.Article

Utilization of eptifibatide for treatment of severe dissections as a bail-out procedureLATSCH, Asvin; SUSELBECK, Tim; MUTH, Nathalie et al.International journal of cardiology. 2004, Vol 96, Num 2, pp 229-233, issn 0167-5273, 5 p.Article

Comparative pharmacology of GP IIb/IIIa antagonistsSCHRÖR, Karsten; WEBER, Artur-Aron.Journal of thrombosis and thrombolysis. 2003, Vol 15, Num 2, pp 71-80, issn 0929-5305, 10 p.Article